NTRK2 and early-onset autosomal dominant Alzheimer disease: This study employed a specific agonist of the BDNF receptor TrkB to elucidate the mechanism by which lidocaine influences BDNF, leading to Alzheimer's disease‐like pathology and cognitive decline.